STEP INTO THE SUMMER SUN: FIRST MAJOR VITAMIN D STUDY

BREAST CANCER NEWS / BREAST CANCER RESEARCH / AUGUST 2, 2011

According to a new study conducted by the University of Rochester Medical Center, low levels of vitamin D are linked to more aggressive tumors and poorer outcomes for breast cancer patients. Many oncologists have long suspected these findings.

In this first major study to research vitamin D and breast cancer progression, researchers linked vitamin D deficiencies with weak scores on every biological marker that helps physicians assess breast cancer outcome.

“There has been suspicion that vitamin D is related to breast health in some way, although the particular pathway is still unknown,” says Dr. Laurie Kirstein, a breast surgeon at New York City’s Beth Israel Medical Center. Many oncologists are already following vitamin D levels in their breast cancer patients, and recommending supplements for low levels. To link vitamin D levels to the aggressiveness…of breast cancer is an interesting finding; one that should be validated with a controlled trial.”

The human body makes vitamin D from sunlight on exposed skin. Other sources of the element include fatty fish and fish oils, fortified dairy products, and oral supplements. Research has shown that African-American and premenopausal women tend to have lower levels of vitamin D when compared with white and older women.

“The magnitude of the findings was quite surprising,” said lead researcher Luke J. Peppone, Ph.D., research assistant professor of Radiation Oncology at the URMC James P. Wilmot Cancer Center. “Based on these results, doctors should strongly consider monitoring vitamin D levels among breast cancer patients and correcting them as needed.”

Take the first step in assessing your vitamin D deficiency risk factors here. You can begin researching more information about the link between vitamin D and breast health through The American Cancer Society and Internal Medicine News.

To discuss this story, visit the Amoena Lifelines blog and leave a comment!

July 6, 2011

Tags: TBCS

Share This On:

Previous Post
syringe FDA Votes to Withdraw Avastin Approval as Late-Stage Breast Cancer Treatment
Next Post
bc_postop_radio Post-Operative Radiation Therapy Cuts Risk of Breast Cancer Return

Breast Care
View All Articles by Breast Care

YOU MIGHT ALSO LIKE

RECENT POSTS
Rx for a Brighter Life: A Strong Dose of Daily Gratitude
Rx for a Brighter Life: A Strong Dose of Daily Gratitude
July 18, 2014
Grass Roots Profile: Art Bra Austin
Grass Roots Profile: Art Bra Austin
July 18, 2014
My Son Also Rises (to the Occasion)
My Son Also Rises (to the Occasion)
July 17, 2014
Healthy Choices: Summer Superfoods
Healthy Choices: Summer Superfoods
July 3, 2014
The Cancer Survivor Handbook
The Cancer Survivor Handbook
July 3, 2014
JOIN OUR MAILING LIST
First Name:

Last Name:

E-Mail:

Yes, I want to receive information about products and services from Amoena.

LIKE THIS? TRY THIS

FDA Votes to Withdraw Avastin Approval as Late-Stage Breast Cancer Treatment
The Food and Drug Administration (FDA) has recommended that Avastin – currently the world’s best-selling cancer drug…

View More In This Category
Follow Us On:

Brought to you by